MTAC vs PYXS
Comparison between MedTech Acquisition Corp - Class A (MTAC, Company) and Pyxis Oncology Inc (PYXS, Company).
MTAC vs PYXS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
MTAC
$183M
Winner
PYXS
$183M
Max Drawdown
Winner
MTAC
13.92%
PYXS
93.57%
Sharpe Ratio
MTAC
0.44
Winner
PYXS
1.43
5Y Beta
MTAC
N/A
PYXS
1.32
Industry
MTAC
N/A
PYXS
Biotechnology
P/E Ratio
Winner
MTAC
-32.94
PYXS
-2.23
Debt to Equity
MTAC
0.00%
PYXS
0.00%
Free Cash Flow Yield
Winner
MTAC
-27.91%
PYXS
-36.51%
P/S Ratio
Winner
MTAC
12.43
PYXS
13.35
P/B Ratio
Winner
MTAC
-12.13
PYXS
5.92
MTAC vs PYXS - Historical Returns
Returns include dividend reinvestment.
1M
MTAC
+7.90%
Winner
PYXS
+15.59%
3M
MTAC
+9.99%
Winner
PYXS
+72.73%
6M
MTAC
+11.55%
Winner
PYXS
+104.03%
1Y
MTAC
+14.55%
Winner
PYXS
+176.36%
5Y(CAGR)
MTAC
N/A
PYXS
-26.27%
Max(CAGR)
Winner
MTAC
+3.05%
PYXS
-26.27%
MTAC vs PYXS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | MTAC | PYXS |
|---|---|---|
| 2026 | N/A | +164.35% |
| 2025 | N/A | -31.95% |
| 2024 | N/A | -24.27% |
| 2023 | +12.84% | +30.43% |
| 2022 | +0.80% | -88.28% |
| 2021 | -6.08% | -16.89% |
MTAC vs PYXS Drawdown Comparison
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The maximum drawdown for PYXS was -93.57%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current PYXS drawdown is -77.71%.
| Rank | MTAC | PYXS |
|---|---|---|
| #1 | -13.92% Feb 19, 2021 - Aug 10, 2023 | -93.57% Nov 4, 2021 - Apr 8, 2025 |
| #2 | -1.90% Feb 8, 2021 - Feb 16, 2021 | -12.95% Oct 8, 2021 - Oct 28, 2021 |
| #3 | N/A | -1.05% Oct 29, 2021 - Nov 3, 2021 |
Correlation
Correlation between MTAC and PYXS is -0.20 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.20
-101
Select Stocks to Compare
Popular: MTAC vs SPYPYXS vs SPY
More Comparisons
Compare with similar stocks